Targeting Energy Metabolism for Cancer Therapeutic Discovery using Agilent Seahorse XF Technology
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Analysis, Assay development optimisation & technology, Business, Cell therapy, Cellular & Molecular biology, Cellular assays, Clinical specialities, Drug development, Drug discovery, Drug targets, Gene therapy, High Content Screening, Molecular medicine, Oncology, Protein chemistry / Proteomics, RNA, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Toxicology
